1077 related articles for article (PubMed ID: 18462352)
1. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
3. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
Quek ML; Stein JP; Nichols PW; Cai J; Miranda G; Groshen S; Daneshmand S; Skinner EC; Skinner DG
J Urol; 2005 Jul; 174(1):103-6. PubMed ID: 15947587
[TBL] [Abstract][Full Text] [Related]
5. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
6. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy.
Palmieri F; Brunocilla E; Bertaccini A; Guidi M; Pernetti R; Morselli-Labate AM; Martorana G
Anticancer Res; 2010 Jul; 30(7):2973-6. PubMed ID: 20683041
[TBL] [Abstract][Full Text] [Related]
8. Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy?
Hong SK; Kwak C; Jeon HG; Lee E; Lee SE
Urology; 2005 Apr; 65(4):697-702. PubMed ID: 15833511
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of bladder cancer patients undergoing radical cystectomy].
Kato Y; Hasegawa Y; Wakita T; Hayashi N
Hinyokika Kiyo; 2005 Nov; 51(11):719-25. PubMed ID: 16363702
[TBL] [Abstract][Full Text] [Related]
10. [Significance of pelvic lymphadenectomy for the prognosis after radical cystectomy].
Leissner J; Allhoff EP; Hohenfellner R; Wolf HK
Zentralbl Chir; 2002 Apr; 127(4):315-21. PubMed ID: 12085284
[TBL] [Abstract][Full Text] [Related]
11. The impact of primary stage on survival in patients with lymph node positive bladder cancer.
Vieweg J; Gschwend JE; Herr HW; Fair WR
J Urol; 1999 Jan; 161(1):72-6. PubMed ID: 10037372
[TBL] [Abstract][Full Text] [Related]
12. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
13. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.
Dhar NB; Klein EA; Reuther AM; Thalmann GN; Madersbacher S; Studer UE
J Urol; 2008 Mar; 179(3):873-8; discussion 878. PubMed ID: 18221953
[TBL] [Abstract][Full Text] [Related]
14. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.
May M; Herrmann E; Bolenz C; Brookman-May S; Tiemann A; Moritz R; Fritsche HM; Burger M; Trojan L; Michel MS; Wülfing C; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Gilfrich C; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Bastian PJ
Ann Surg Oncol; 2011 Jul; 18(7):2018-25. PubMed ID: 21246405
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors of invasive bladder cancer with lymph node invasion].
Lacroix B; Rusch P; Cerisier A; Pages A; Armand C; Tostain J
Prog Urol; 2002 Sep; 12(4):615-20. PubMed ID: 12463120
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of lymph node dissections in bladder cancer treated with radical cystectomy].
Braud G; Battisti S; Karam G; Bouchot O; Rigaud J
Prog Urol; 2008 Jun; 18(6):351-7. PubMed ID: 18558323
[TBL] [Abstract][Full Text] [Related]
17. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy.
Kassouf W; Leibovici D; Munsell MF; Dinney CP; Grossman HB; Kamat AM
J Urol; 2006 Jul; 176(1):53-7; discussion 57. PubMed ID: 16753366
[TBL] [Abstract][Full Text] [Related]
19. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
[TBL] [Abstract][Full Text] [Related]
20. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
